🇺🇸 FDA
Pipeline program

Sofosbuvir

GS-US-334-0115

Phase 3 small_molecule completed

Quick answer

Sofosbuvir for Chronic HCV Infection is a Phase 3 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
Chronic HCV Infection
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials